Humanin vs NAD+ Precursors
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: HN, HNG (S14G-humanin)
A mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Also: NMN, NR
While not peptides, NAD+ precursors are frequently discussed alongside peptides in longevity circles. They boost cellular NAD+ levels, supporting energy metabolism and sirtuin activity.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- NAD+ Precursors has stronger research evidence (Human Trials) compared to Humanin (Animal Studies).
Detailed Comparison
| Attribute | Humanin | NAD+ Precursors |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Humanin acts through multiple pathways including STAT3 signaling, binding to IGFBP-3, and activating the FPRL1 receptor. It protects neurons from apoptosis, improves insulin sensitivity, and has anti-inflammatory effects. | NMN and NR are converted to NAD+ in cells. NAD+ is essential for mitochondrial function, DNA repair, and sirtuin enzyme activity. Sirtuins regulate metabolism, stress response, and longevity pathways. NAD+ levels decline with age. |
| Common Dosing | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) | Limited community data available See research protocols |
| Administration | Injection (route varies) | Oral (capsules, sublingual) |
| Typical Duration | Variable | Ongoing supplementation |
| Best Time to Take | Morning | Morning or before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Research shows protection against amyloid-beta toxicity in Alzheimer's models. Studies demonstrate improved insulin sensitivity, reduced atherosclerosis in animal models, and potential anti-aging effects. Human studies are limited. | Animal studies show improved metabolic function, enhanced exercise capacity, and extended healthspan. Human trials demonstrate safety and NAD+ elevation. Long-term benefits in humans still being established. David Sinclair's research popularized the field. |
Frequently Asked Questions: Humanin vs NAD+ Precursors
What is the difference between Humanin and NAD+ Precursors?
Humanin is a anti-aging peptide that a mitochondria-derived peptide discovered for its neuroprotective effects against alzheimer's-related toxicity. being studied for aging and metabolic benefits. NAD+ Precursors is a anti-aging peptide that while not peptides, nad+ precursors are frequently discussed alongside peptides in longevity circles. they boost cellular nad+ levels, supporting energy metabolism and sirtuin activity. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Humanin or NAD+ Precursors?
Neither is universally "better" - the choice depends on your specific goals. Humanin is typically used for anti-aging purposes, while NAD+ Precursors is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Humanin and NAD+ Precursors be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Humanin and NAD+ Precursors together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.